Skip to content

Evaluation of the Warwick Axial Spondyloarthritis Fatigue and Energy questionnaire (e-WASTEd)) in rheumatology clinical practice.

Measuring fatigue in Axial Spondyloarthritis (axSpA): refinement, application and evaluation of a new electronic patient-reported outcome measure (the Warwick Axial Spondyloarthritis Fatigue and Energy questionnaire (e-WASTEd)) in rheumatology clinical practice.

Status
Active, not recruiting
Phases
Unknown
Study type
Observational
Source
ISRCTN
Registry ID
ISRCTN64318436
Enrollment
411
Registered
2023-10-19
Start date
2022-09-26
Completion date
Unknown
Last updated
2024-08-12

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Axial spondyloarthritis Musculoskeletal Diseases

Interventions

Stage 1: Refining the WASTEd-Short Form 1.1. Qualitative interviews (paper version of WASTEd): Three rounds of semi-structured interviews (online/by phone) with people with axial spondyloarthritis, pr
hence, patients with significantly limited literacy levels are excluded. This extends to pa

Sponsors

University of Warwick
Lead Sponsor

Eligibility

Sex/Gender
All

Inclusion criteria

Inclusion criteria: Patients: 1. Adults aged 18 years old and over 2. A confirmed diagnosis of axSpA 3. Registered with participating rheumatology centres 4. Access to a computer or tablet device to allow for receipt of the e-mail and e-WASTEd completion Health professionals: Experience of using the BSR ePROM portal with their patients

Exclusion criteria

Exclusion criteria: 1. Ability to understand written English to a readability level of 11-13 years 2. Patients with significant co-morbidities

Design outcomes

Primary

MeasureTime frame
Fatigue and energy measured using the WASTEd 18-item questionniare at baseline, 2-week and 3-month follow-up

Secondary

MeasureTime frame
The following secondary outcome measures are assessed at baseline, 2-week and 3-month follow-up: 1. Health-related quality of life measured using the EQ-5D five questionnaire descriptive system and the EQ visual analogue scale (EQ VAS) 2. Self-reported fatigue and its impact upon daily activities and function measured using the Functional Assessment of Chronic Illness Therapy – Fatigue Scale (FACIT-Fatigue) 5-point Likert-type scale comprising 13 items 3. Anxiety and depression symptoms measured using the Hospital Anxiety and Depression Score (HADS) 4-point Likert-type scale comprising 14 items 4. Pain measured using a single measure of pain severity using an 11-point numerical rating scale 5. Four domains of physical function, disease activity, emotional well-being and social participation measured using the Evaluation of Ankylosing Spondylitis Quality of Life (EASi-QoL) 5-point Likert-type scale comprising 20 items 6. Functional and disease activity indices measured using the Bath Ankylosing Spondylitis Disease Activity Index (BASDAI) comprising a 0 - 10 scale measuring discomfort, pain, and fatigue (0 being no problem and 10 being the worst problem) in response to six questions 7. Functional anatomical limitations due to the course of this inflammatory disease and the patient’s ability to cope with everyday life measured using the Bath Ankylosing Spondylitis Functional Index (BASFI) comprising 10 VAS questions

Countries

England, Scotland, United Kingdom, Wales

Outcome results

None listed

Source: ISRCTN (via WHO ICTRP) · Data processed: Feb 4, 2026